Prospects for a vaccine against otitis media (Q36600356)

15 August 2017

1 reference

title

Prospects for a vaccine against otitis media (English)

1 reference

15 August 2017

Allan W Cripps

1

1 reference

15 August 2017

Diana C Otczyk

series ordinal

2

1 reference

15 August 2017

publication date

1 August 2006

1 reference

Expert Review of Vaccines

15 August 2017

published in

1 reference

15 August 2017

volume

5

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

517-534

1 reference

Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years. Greater Boston Otitis Media Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Behaviour and developmental effects of otitis media with effusion into the teens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Antimicrobial use in defined populations of infants and young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Excessive antibiotic use for acute respiratory infections in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Initial and follow-up costs by treatment outcome for children with respiratory infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Changes in frequency and pathogens causing acute otitis media in 1995-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Diagnosis and management of acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Dynamics of nasopharyngeal colonization by potential respiratory pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Importance of respiratory viruses in acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Bacteriological and PCR analysis of clinical material aspirated from otitis media with effusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Association of rhinovirus infection with poor bacteriologic outcome of bacterial-viral otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Multiplex nested reverse transcription-polymerase chain reaction for respiratory viruses in acute otitis media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Meta-analysis of tympanostomy tube sequelae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

The potential indirect effect of conjugate pneumococcal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Acute otitis media caused by Streptococcus pyogenes in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Vaccines for otitis media: proposals for overcoming obstacles to progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Chinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Clonal analysis of invasive pneumococcal isolates in Scotland and coverage of serotypes by the licensed conjugate polysaccharide pneumococcal vaccine: possible implications for UK vaccine policy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Salivary antibodies induced by the seven-valent PncCRM conjugate vaccine in the Finnish Otitis Media Vaccine Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Impact of the pneumococcal conjugate vaccine on otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Immunogenicity and efficacy of Streptococcus pneumoniae polysaccharide-protein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Maternal pneumococcal conjugate immunization protects infant chinchillas in the pneumococcal otitis media model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Immunization with native or recombinant Streptococcus pneumoniae neuraminidase affords protection in the chinchilla otitis media model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

The structural heterogeneity of the lipooligosaccharide (LOS) expressed by pathogenic non-typeable Haemophilus influenzae strain NTHi 9274.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Phase I study of a lipooligosaccharide-based conjugate vaccine against nontypeable Haemophilus influenzae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Induction of specific immunoglobulin A and Th2 immune responses to P6 outer membrane protein of nontypeable Haemophilus influenzae in middle ear mucosa by intranasal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Antibodies to loop 6 of the P2 porin protein of nontypeable Haemophilus influenzae are bactericidal against multiple strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Human antibodies specific for the high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae mediate opsonophagocytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Immunization with Haemophilus influenzae Hap adhesin protects against nasopharyngeal colonization in experimental mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

The C-terminal fragment of the internal 110-kilodalton passenger domain of the Hap protein of nontypeable Haemophilus influenzae is a potential vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Purification and characterization of a recombinant Haemophilus influenzae outer membrane phosphomonoesterase e (P4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Certain site-directed, nonenzymatically active mutants of the Haemophilus influenzae P4 lipoprotein are able to elicit bactericidal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Conjugated heptavalent pneumococcal vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Correlates of immunity for pneumococcal conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Otitis Media With Effusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

Molecular Analysis of Bacterial Pathogens in Otitis Media With Effusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.4.517

21 January 2018

Identifiers

DOI

10.1586/14760584.5.4.517

1 reference

15 August 2017

1 reference